GL1X · GenesisL1 explorer

Research workbench

Human KRAS in complex with darpin K13

Analyse Human KRAS in complex with darpin K13 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6H46
Type
protein
Length
324 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS; Darpin K13
UniProt
P01116
Ligands
GDP, SO4
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 47% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGTPase KRASprotein16839% helix, 23% strandP01116
BDarpin K13protein15655% helix, 0% strand—

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11720.570.8129empty
2600.320.7618empty
3530.270.7411empty

Interfaces

1 interface between chains.

  • A–B · 1046 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 6H46 · Human KRAS in complex with darpin K13 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.